Mohammed Kashani-Sabet, MD is Medical Director of Sutter Health’s Oncology Service Line. He also serves as Medical Director of the California Pacific Medical Center (CPMC) Cancer Center, as well as director of the Center for Melanoma Research and Treatment at CPMC, and senior scientist at the CPMC Research Institute. Dr. Kashani-Sabet earned his medical degree from the State University of New York at Stony Brook, where he also completed an internship in internal medicine. He then completed a residency in dermatology at the University of California, San Francisco, as well as a post-doctoral fellowship in cutaneous oncology, where he received training in both dermatology and medical oncology. Dr. Kashani-Sabet’s clinical practice is focused on patients with melanoma and cutaneous lymphoma. His research interests include tumor biomarkers, targeted therapies, prognostic modeling, and tumor metastasis. He has served as principal or co-investigator of several clinical trials of novel agents for melanoma and cutaneous lymphoma. He is a recipient of grant funding from the National Institutes of Health and the Department of Defense and has served on several study sections for the National Cancer Institute. He has served on the editorial board of Journal of Translational Medicine, Cancer Gene Therapy, and Oncology Letters, and has served as an ad hoc reviewer for numerous journals, including The Lancet, Annals of Internal Medicine, and Journal of the National Cancer Institute. The author of over 200 peer-reviewed publications and 40 review articles/book chapters, as well as editor of 2 textbooks, Dr. Kashani-Sabet has been an invited speaker at numerous regional, national, and international meetings. In 2014, he was recipient of the Humanitarian Award from the Melanoma Research Foundation.